NCT01387321View on ClinicalTrials.gov

A Study of BYL719 in Adult Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 22, 2011

Primary Completion Date

November 25, 2015

Study Completion Date

November 25, 2015

Conditions
Advanced Solid Tumor
Interventions
DRUG

BYL719

Trial Locations (4)

460-0001

Novartis Investigative Site, Nagoya

466 8560

Novartis Investigative Site, Nagoya

104-0045

Novartis Investigative Site, Chuo-ku

135 8550

Novartis Investigative Site, Koto-ku

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY